MENU
TIL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Instil Bio (TIL) Earnings Date & Reports

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer... Show more

A.I. Advisor
published Earnings

TIL is expected to report earnings to fall 81.73% to -189 cents per share on March 04

Instil Bio TIL Stock Earnings Reports
Q4'23
Est.
$-1.90
Q3'23
Missed
by $4.30
Q2'23
Beat
by $0.01
Q1'23
Missed
by $8.51
Q4'22
Missed
by $6.79
The last earnings report on November 13 showed earnings per share of -1039 cents, missing the estimate of -609 cents. With 36.26K shares outstanding, the current market capitalization sits at 119.49M.
View a ticker or compare two or three
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company engaged in the reinsurance business

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Precious Metals
Address
3963 Maple Avenue
Phone
+1 972 499-3350
Employees
49
Web
https://www.instilbio.com